Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial Of Avastin (Bevacizumab) In Patients With Metastatic Papillary Renal Cell Carcinoma

NCT00601926 is registered in ClinicalTrials.gov with Paul Monk as lead sponsor.

NCT NCT00601926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00601926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial Of Avastin (Bevacizumab) In Patients With Metastatic Papillary Renal Cell Carcinoma
Lead sponsor
Paul Monk
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2008
Completion date
May 31, 2013
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer